Summary of TRANZYME INC - Yahoo! Finance

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

TZYM > SEC Filings for TZYM > Form 8-K on 15-Nov-2012

All Recent SEC Filings

Show all filings for TRANZYME INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for TRANZYME INC

15-Nov-2012

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On November 15, 2012, Tranzyme, Inc. issued a press release announcing the completion and results of the first of two Phase 2b trials evaluating the efficacy and safety of its oral ghrelin agonist TZP-102 in diabetic patients with gastroparesis. The full text of the press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press release of Tranzyme, Inc. dated November 15, 2012.

Add TZYM to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for TZYM - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.